UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 5, 2013
(Exact name of registrant as specified in its charter)
|
Delaware
|
0-21121
|
06-1456680
|
|
(State or other jurisdiction of incorporation)
|
(Commission file number)
|
(I.R.S. employer identification no.)
|
|
One Hamden Center
|
|
|
2319 Whitney Ave, Suite 3B, Hamden, CT
|
06518
|
|
(Address of principal executive offices)
|
(Zip Code)
|
Registrant's telephone number, including area code: (203) 859-6800
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240-14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 2.02 Results of Operations and Financial Condition.
The following information is being furnished pursuant to Item 2.02 “Results of Operations and Financial Condition” of Form 8-K. Such information, including the Exhibit attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.
On August 5, 2013, TransAct Technologies Incorporated (“TransAct”) announced that its Board of Directors declared a quarterly dividend on its Common Stock in the amount of $.07 per share payable on or about September 13, 2013 to common shareholders of record at the close of business on August 20, 2013. A copy of the press release is furnished as Exhibit 99.1 to this report.
On August 6, 2013, TransAct issued a press release announcing its financial results for the quarter ended June 30, 2013. A copy of the press release is furnished as Exhibit 99.2 to this report.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits:
|
Exhibit
|
Description
|
|
|
99.1
|
Press Release dated August 5, 2013 of TransAct Technologies Incorporated
|
|
|
99.2
|
Press Release dated August 6, 2013 of TransAct Technologies Incorporated
|
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
TRANSACT TECHNOLOGIES INCORPORATED
|
||||
|
By:
|
/s/Steven A. DeMartino
|
|||
|
Steven A. DeMartino
|
||||
|
President, Chief Financial Officer, Treasurer and Secretary
|
||||
Date: August 6, 2013
Exhibit 99.1
TRANSACT TECHNOLOGIES DECLARES QUARTERLY
CASH DIVIDEND OF $0.07 PER SHARE
HAMDEN, CT – August 5, 2013 – TransAct Technologies Incorporated (Nasdaq: TACT), a global leader in market-specific solutions, including printers, terminals, software and other products for transaction-based and other industries, announced today that its Board of Directors declared a quarterly cash dividend of $0.07 per share, payable September 13, 2013 to shareholders of record at the close of business on August 20, 2013. On an annualized basis, the quarterly dividend represents an annual yield of 3.1% based on the $8.99 per share closing price of the Company’s stock on August 2, 2013.
About TransAct Technologies Incorporated
TransAct Technologies Incorporated is a leader in developing and manufacturing market-specific solutions, including printers, terminals, software and other products for transaction-based and other industries. These industries include casino and gaming, lottery, food safety, banking, point-of-sale, hospitality, oil and gas, and medical and mobile. Each individual market has distinct, critical requirements for printing and the transaction is not complete until the receipt and/or ticket is produced. TransAct printers and products are designed from the ground up based on market-specific requirements and are sold under the Ithaca®, Epic, EPICENTRAL® and Printrex® product brands. TransAct distributes its printers through OEMs, value-added resellers, selected distributors, and direct to end-users. TransAct has over 2.4 million printers installed around the world. TransAct is also committed to providing world-class printer service, spare parts, accessories and printing supplies to its growing worldwide installed base of printers. Through its TransAct Services Group, TransAct provides a complete range of supplies and consumable items used in the printing and scanning activities of customers in the hospitality, banking, retail, gaming, government and oil and gas exploration markets. Through its webstore, http://www.transactsupplies.com, and a direct selling team, TransAct addresses the on-line demand for these products. TransAct is headquartered in Hamden, CT. For more information, please visit http://www.transact-tech.com or call 203.859.6800.
Forward-Looking Statements
Certain statements in this press release include forward-looking statements. Forward-looking statements generally can be identified by the use of forward-looking terminology, such as "may", "will", "expect", "intend", "estimate", "anticipate", "believe" or "continue" or the negative thereof or other similar words. All forward-looking statements involve risks and uncertainties, including, but are not limited to, customer acceptance and market share gains, both domestically and internationally, in the face of substantial competition from competitors that have broader lines of products and greater financial resources; our competitors introducing new products into the marketplace; our ability to successfully develop new products; our dependence on significant customers; our dependence on significant vendors; dependence on contract manufacturers for the assembly of a large portion of our products in China; our ability to protect intellectual property; our ability to recruit and retain quality employees as the Company grows; our dependence on third parties for sales outside the United States, including Australia, New Zealand, Europe, Latin America and Asia; the economic and political conditions in the United States, Australia, New Zealand, Europe, Latin America and Asia; marketplace acceptance of new products; risks associated with foreign operations; the availability of third-party components at reasonable prices; price wars or other significant pricing pressures affecting the Company's products in the United States or abroad; risks associated with potential future acquisitions; our new line of food safety and oil and gas products will drive increased adoption by customers; the outcome of the lawsuit between TransAct and Avery Dennison Corporation; and other risk factors detailed from time to time in TransAct's reports filed with the Securities and Exchange Commission. Actual results may differ materially from those discussed in, or implied by, the forward-looking statements. The forward-looking statements speak only as of the date of this release and the Company assumes no duty to update them to reflect new, changing or unanticipated events or circumstances.
# # #
Investor Contact:
Steve DeMartino Richard Land, Joseph Jaffoni, Jim Leahy
President and Chief Financial Officer JCIR
TransAct Technologies Incorporated 212-835-8500 or tact@jcir.com
203-859-6810
Exhibit 99.2
TRANSACT TECHNOLOGIES REPORTS SECOND QUARTER REVENUE
OF $15.8 MILLION AND DILUTED EPS OF $0.14
- Gross Margin Improves to 40.9%; Operating Income Rises 132%
and Adjusted EBITDA Increases 18% to $2.2 Million -
Hamden, CT – August 6, 2013 – TransAct Technologies Incorporated (Nasdaq: TACT) (“TransAct’ or the “Company”) today reported operating results for the second quarter ended June 30, 2013, as summarized below:
Summary of 2013 Q2 Results
(In millions, except per share and percentage data)
|
Three Months Ended
June 30,
|
||||||
|
2013
|
2012
|
|||||
|
Net sales
|
$ | 15.8 | $ | 15.9 | ||
|
Gross profit
|
$ | 6.5 | $ | 5.8 | ||
|
Gross margin
|
40.9% | 36.9% | ||||
|
Operating income
|
$ | 1.8 | $ | 0.8 | ||
|
Net income
|
$ | 1.2 | $ | 0.5 | ||
|
Diluted earnings per share
|
$ | 0.14 | $ | 0.06 | ||
|
Adjusted EBITDA(1)
|
$ | 2.2 | $ | 1.9 | ||
|
Adjusted operating income(2)
|
$ | 1.7 | $ | 1.3 | ||
|
Adjusted net income(2)
|
$ | 1.1 | $ | 0.9 | ||
|
Adjusted diluted earnings per share(2)
|
$ | 0.13 | $ | 0.09 | ||
|
(1)
|
Adjusted EBITDA is defined as net income before net interest expense, income taxes, depreciation, amortization and stock-based compensation and adjusted for the impact of acquisition related expenses, restructuring expenses and certain legal fees as described later in this release. A reconciliation of Adjusted EBITDA to net income, the most comparable Generally Accepted Accounting Principles (“GAAP”) financial measure, can be found attached to this release.
|
|
(2)
|
Reconciliations of GAAP earnings financial metrics to corresponding non-GAAP financial measures can be found attached to this release.
|
Bart Shuldman, Chairman and Chief Executive Officer of TransAct, commented, “Our growth in 2013 second quarter gross profit and gross margin drove significant increases in adjusted EBITDA and diluted EPS and adjusted diluted EPS compared to the same period a year ago. The strong second quarter financial performance highlights the benefits of our ongoing expansion into new, higher margin markets and continued progress in bringing innovation and value to customers in existing markets. Our strategic initiatives, focused on developing and marketing products and technologies for large, diversified domestic and international markets, continue to provide TransAct with opportunities in fast growing verticals such as food safety, oil and gas exploration and casino promotional and couponing systems.
“Our transition to new markets and opportunities that leverage the Company’s expertise in creating new, value-added solutions for transaction-based businesses has enabled TransAct to successfully launch three new products since the beginning of 2012. Each of these products has advanced features and functionality and generates higher average selling prices and gross margins than our existing products for these markets. Building on our expertise in the casino industry, we are now proving the value of our Epicentral® casino system, which is live at four casinos with three additional casinos scheduled to come online by the end of 2013. In its initial installations, Epicentral® is proving to be a strong marketing tool that rewards guests in new ways and helps casino operators grow revenue at their facilities. We expect the number of Epicentral® installations to grow over the balance of 2013 and throughout 2014, which will drive higher overall revenue and higher-margin annual recurring maintenance revenue.
“In the 2013 second quarter, we generated solid revenue growth from the sale of the Ithaca® 9700 food safety terminal, which accounted for over 50% of the total revenue in our food safety, point-of-sale and banking unit. With a total addressable market of approximately 700,000 terminals in restaurants, hospitals, convenience stores, corporate foodservice operations and schools, the global food safety market represents a large and untapped opportunity for TransAct. There is already strong market interest in the Ithaca® 9700 with a growing number of product trials, and as this innovative solution continues to prove its value, we expect to continue to transition trials to sales.
“Our line of Printrex color printers for the global oil and gas exploration industry is another recent product offering with a high level of customer interest. Leveraging our large installed base of black and white printers, we are in the early stages of a multi-year replacement cycle for the Printrex 920 and Printrex 980 full color solutions which we expect will be another source of recurring revenue growth going forward. Finally, our TransAct Services Group (TSG) provides post-sale fulfillment and services through three global service centers and a newly upgraded website that together provide customers with efficient, easy to use options. TSG and its recurring, high-margin revenue model present the Company with another channel of long-term growth.”
Mr. Shuldman concluded, “Over the last several years, TransAct has made substantial progress with transitioning the business by expanding the number of higher margin products we offer and increasing the number of global markets we address. Our new, innovative solutions enhance our product suite and are driving growing levels of customer adoption as they deliver proven results. At the same time, these initiatives offer TransAct substantial growth and diversification opportunities in new verticals. We expect the momentum achieved in the first half of 2013 will continue in the second half of the year as higher sales of our newest products drive further gains in revenue, gross margin and diluted earnings per share.”
Summary of 2013 Second Quarter Operating Results
TransAct generated 2013 second quarter net sales of $15.8 million compared with net sales of $15.9 million for the 2012 second quarter. Casino and gaming revenue in the 2013 second quarter increased $0.2 million, or 3%, to $7.3 million compared to $7.1 million in the prior year period. Food safety, point-of-sale (POS) and banking net sales increased 29%, or $0.8 million, to $3.5 million compared to $2.7 million in the prior year period. The increase reflects the first volume sales of Ithaca® 9700 food safety terminals for several quick service and casual restaurant franchises, more than offsetting declines in revenue from sales of TransAct’s banking and legacy POS printers as the Company continues to transition away from these lower margin markets. Lottery sales for the 2013 second quarter declined to $0.5 million from $1.7 million in the 2012 second quarter reflecting the timing of orders from GTECH. Revenue from Printrex® printers of $1.1 million in the 2013 second quarter compares to revenue of $1.2 million in the year-ago period as sales of TransAct’s new color printers were more than offset by a decline in sales of legacy black and white printers. The Company’s TransAct Services Group recorded net sales of $3.5 million, a 10%, or $0.3 million, year-over-year increase.
Reflecting the shift toward higher margin products, gross margin improved 400 basis points to 40.9% from 36.9% in the second quarter of 2012, resulting in gross profit of $6.5 million. Total operating expenses for the 2013 second quarter declined to $4.6 million from $5.1 million a year ago. Selling and marketing expenses increased $0.2 million to $1.9 million, reflecting the addition of sales staff and higher marketing expenses to support the Company’s recently introduced food safety and Printrex products. General and administrative expenses declined by $0.2 million primarily due to a reduction in the accrued contingent consideration liability to be paid in connection with the Company’s 2011 acquisition of Printrex. In addition, TransAct incurred approximately $0.1 million in legal fees related to the lawsuit with Avery Dennison Corporation in the 2013 second quarter compared to $0.5 million in the 2012 second quarter.
Operating income for the 2013 second quarter was $1.8 million compared to $0.8 million in the 2012 second quarter. Excluding the impact from several items (see details later in the release), TransAct generated adjusted operating income of $1.7 million compared with adjusted operating income of $1.3 million in the year-ago period. Net income in the 2013 second quarter was $1.2 million, or $0.14 per diluted share, compared to net income of $0.5 million, or $0.06 per diluted share in the prior-year period. Adjusted net income was $1.1 million, or $0.13 per diluted share, compared to $0.9 million, or $0.09 per diluted share, in the 2012 second quarter.
Solid Balance Sheet and Liquidity Position
As of June 30, 2013, TransAct had approximately $8.8 million of cash and cash equivalents and no debt. In the first six months of 2013, the Company generated cash from operating activities of $3.3 million and free cash flow (cash from operating activities less capital expenditures) of $2.8 million. TransAct repurchased approximately 25,300 shares of its common stock in the 2013 second quarter at an average price of $7.72 per share for total consideration of $0.2 million, and has repurchased approximately 114,200 shares of its common stock in the first six months of 2013 for total consideration of approximately $0.9 million. The Company’s share repurchase program expired in May 2013. The Company also paid a dividend to shareholders of $0.07 per share during the quarter.
Steve DeMartino, President and Chief Financial Officer of TransAct, commented, “Our solid financial position and emphasis on prudent management of operating expenses have positioned TransAct to develop and introduce new and innovative higher margin products for existing and new global markets, grow recurring revenue and generate solid improvements in both operating income and EBITDA. As we successfully execute on this transition, TransAct has increasing financial flexibility to deploy capital for growth opportunities across multiple verticals including gaming, food safety and oil and gas exploration while simultaneously returning capital to shareholders.”
2013 Second Quarter Conference Call and Webcast
TransAct is hosting a conference call and webcast today, August 6, 2013, beginning at 4:30 p.m. ET. Both the call and the webcast are open to the general public. The conference call number is 678-825-8259 (domestic or international). Please call five minutes prior to the presentation to ensure that you are connected.
Interested parties may also access the conference call live on the Internet at www.transact-tech.com (select “Investor Relations” followed by “Events & Presentations”). Approximately two hours after the call has concluded, an archived version of the webcast will be available for replay at the same location.
Non-GAAP Financial Measures
TransAct has provided adjusted non-GAAP financial measures because the Company believes that these amounts are helpful to investors and others to more accurately assess the ongoing nature of TransAct's core operations. The adjusted non-GAAP measures exclude the effect in the applicable periods presented of non-GAAP adjustments contained in the tables included with this release. These items have been excluded from adjusted non-GAAP financial measures as management does not believe that they are representative of underlying trends in the Company's performance. Their exclusion provides investors and others with additional information to more readily assess the Company's operating results. The Company uses the non-GAAP financial measures internally to focus management on the results of the Company's core business. The presentation of this additional non-GAAP information is not considered superior to or a substitute for the financial information prepared in accordance with GAAP.
Adjusted operating income is defined as operating income adjusted for the impact of acquisition related expenses, business consolidation and restructuring expenses and legal fees related to the lawsuit with Avery Dennison Corporation.
Adjusted net income is defined as net income adjusted for the tax-effected impact of acquisition related expenses, business consolidation and restructuring expenses and legal fees related to the lawsuit with Avery Dennison Corporation.
Adjusted diluted earnings per share is defined as Adjusted Net Income divided by diluted shares outstanding.
About TransAct Technologies Incorporated
TransAct Technologies Incorporated is a leader in developing and manufacturing market-specific solutions, including printers, terminals, software and other products for transaction-based and other industries. These industries include casino and gaming, lottery, food safety, banking, point-of-sale, hospitality, oil and gas, and medical and mobile. Each individual market has distinct, critical requirements for printing and the transaction is not complete until the receipt and/or ticket is produced. TransAct printers and products are designed from the ground up based on market-specific requirements and are sold under the Ithaca®, Epic, EPICENTRAL® and Printrex® product brands. TransAct distributes its printers through OEMs, value-added resellers, selected distributors, and direct to end-users. TransAct has over 2.4 million printers installed around the world. TransAct is also committed to providing world-class printer service, spare parts, accessories and printing supplies to its growing worldwide installed base of printers. Through its TransAct Services Group, TransAct provides a complete range of supplies and consumable items used in the printing and scanning activities of customers in the hospitality, banking, retail, gaming, government and oil and gas exploration markets. Through its webstore, http://www.transactsupplies.com, and a direct selling team, TransAct addresses the on-line demand for these products. TransAct is headquartered in Hamden, CT. For more information, please visit http://www.transact-tech.com or call 203.859.6800.
Forward-Looking Statements
Certain statements in this press release include forward-looking statements. Forward-looking statements generally can be identified by the use of forward-looking terminology, such as "may", "will", "expect", "intend", "estimate", "anticipate", "believe" or "continue" or the negative thereof or other similar words. All forward-looking statements involve risks and uncertainties, including, but are not limited to, customer acceptance and market share gains, both domestically and internationally, in the face of substantial competition from competitors that have broader lines of products and greater financial resources; our competitors introducing new products into the marketplace; our ability to successfully develop new products; our dependence on significant customers; our dependence on significant vendors; dependence on contract manufacturers for the assembly of a large portion of our products in China; our ability to protect intellectual property; our ability to recruit and retain quality employees as the Company grows; our dependence on third parties for sales outside the United States, including Australia, New Zealand, Europe, Latin America and Asia; the economic and political conditions in the United States, Australia, New Zealand, Europe, Latin America and Asia; marketplace acceptance of new products; risks associated with foreign operations; the availability of third-party components at reasonable prices; price wars or other significant pricing pressures affecting the Company's products in the United States or abroad; risks associated with potential future acquisitions; our new line of food safety and oil and gas products will drive increased adoption by customers; the outcome of the lawsuit between TransAct and Avery Dennison Corporation; and other risk factors detailed from time to time in TransAct's reports filed with the Securities and Exchange Commission. Actual results may differ materially from those discussed in, or implied by, the forward-looking statements. The forward-looking statements speak only as of the date of this release and the Company assumes no duty to update them to reflect new, changing or unanticipated events or circumstances.
# # #
Investor Contact:
Steve DeMartino Richard Land, Joseph Jaffoni, Jim Leahy
President and Chief Financial Officer JCIR
TransAct Technologies Incorporated 212-835-8500 or tact@jcir.com
203-859-6810
- Financial tables follow -
|
TRANSACT TECHNOLOGIES INCORPORATED
|
||||||||||||
|
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
|
||||||||||||
|
(Unaudited)
|
||||||||||||
|
Three Months Ended
|
Six Months Ended
|
|||||||||||
|
(In thousands, except per share amounts)
|
June 30, June 30, | |||||||||||
|
2013 2012
|
2013
|
2012
|
||||||||||
|
Net sales
|
$ | 15,788 | $ | 15,853 | $ | 30,845 | $ | 33,412 | ||||
|
Cost of sales
|
9,336 | 10,011 | 17,960 | 20,792 | ||||||||
|
Gross profit
|
6,452 | 5,842 | 12,885 | 12,620 | ||||||||
|
Operating expenses:
|
||||||||||||
|
Engineering, design and product development
|
995 | 952 | 2,007 | 2,165 | ||||||||
|
Selling and marketing
|
1,857 | 1,674 | 3,643 | 3,275 | ||||||||
|
General and administrative
|
1,736 | 1,903 | 3,770 | 3,903 | ||||||||
|
Legal fees associated with lawsuit
|
57 | 471 | 256 | 471 | ||||||||
|
Business consolidation and restructuring
|
- | 63 | - | 117 | ||||||||
| 4,645 | 5,063 | 9,676 | 9,931 | |||||||||
|
Operating income
|
1,807 | 779 | 3,209 | 2,689 | ||||||||
|
Interest and other income (expense):
|
||||||||||||
|
Interest, net
|
- | 2 | (1) | 4 | ||||||||
|
Other, net
|
(4) | 13 | 33 | (11) | ||||||||
| (4) | 15 | 32 | (7) | |||||||||
|
Income before income taxes
|
1,803 | 794 | 3,241 | 2,682 | ||||||||
|
Income tax provision
|
588 | 286 | 866 | 966 | ||||||||
|
Net income
|
$ | 1,215 | $ | 508 | 2,375 | $ | 1,716 | |||||
|
Net income per common share:
|
||||||||||||
|
Basic
|
$ | 0.14 | $ | 0.06 | $ | 0.27 | $ | 0.19 | ||||
|
Diluted
|
$ | 0.14 | $ | 0.06 | $ | 0.27 | $ | 0.18 | ||||
|
Shares used in per share calculation:
|
||||||||||||
|
Basic
|
8,728 | 9,084 | 8,722 | 9,256 | ||||||||
|
Diluted
|
8,802 | 9,189 | 8,803 | 9,357 | ||||||||
|
SUPPLEMENTAL INFORMATION – SALES BY SALES UNIT:
|
|||||||||||||||
|
Three months ended
|
Six months ended
|
||||||||||||||
|
June 30,
|
June 30,
|
||||||||||||||
|
2013
|
2012
|
2013
|
2012
|
||||||||||||
|
Food safety, point-of-sale and banking
|
$ | 3,453 | $ | 2,676 | $ | 5,437 | $ | 5,012 | |||||||
|
Casino and gaming
|
7,322 | 7,112 | 14,062 | 16,523 | |||||||||||
|
Lottery
|
499 | 1,728 | 1,864 | 2,758 | |||||||||||
|
Printrex
|
1,050 | 1,174 | 2,375 | 2,413 | |||||||||||
|
TransAct Services Group
|
3,464 | 3,163 | 7,107 | 6,706 | |||||||||||
|
Total net sales
|
$ | 15,788 | $ | 15,853 | $ | 30,845 | $ | 33,412 | |||||||
|
TRANSACT TECHNOLOGIES INCORPORATED
|
||||||
|
CONDENSED CONSOLIDATED BALANCE SHEETS
|
||||||
|
(Unaudited)
|
||||||
|
June 30,
|
December 31,
|
|||||
|
(In thousands)
|
2013
|
2012
|
||||
|
Assets:
|
||||||
|
Current assets:
|
||||||
|
Cash and cash equivalents
|
$ | 8,828 | $ | 7,537 | ||
|
Accounts receivable, net
|
11,640 | 15,927 | ||||
|
Inventories
|
12,787 | 10,321 | ||||
|
Deferred tax assets
|
1,443 | 1,443 | ||||
|
Other current assets
|
666 | 471 | ||||
|
Total current assets
|
35,364 | 35,699 | ||||
|
Fixed assets, net
|
3,105 | 3,302 | ||||
|
Goodwill
|
2,621 | 2,621 | ||||
|
Deferred tax assets
|
1,113 | 1,172 | ||||
|
Intangible assets, net
|
2,113 | 2,328 | ||||
|
Other assets
|
79 | 106 | ||||
| 9,031 | 9,529 | |||||
|
Total assets
|
$ | 44,395 | $ | 45,228 | ||
|
Liabilities and Shareholders’ Equity:
|
||||||
|
Current liabilities:
|
||||||
|
Accounts payable
|
$ | 5,603 | $ | 6,422 | ||
|
Accrued liabilities
|
2,391 | 2,927 | ||||
|
Income taxes payable
|
121 | 629 | ||||
|
Accrued contingent consideration
|
230 | 136 | ||||
|
Deferred revenue
|
197 | 93 | ||||
|
Total current liabilities
|
8,542 | 10,207 | ||||
|
Deferred revenue, net of current portion
|
166 | 168 | ||||
|
Deferred rent, net of current portion
|
278 | 308 | ||||
|
Accrued acquisition consideration, net of current portion
|
530 | 824 | ||||
|
Other liabilities
|
383 | 352 | ||||
| 1,357 | 1,652 | |||||
|
Total liabilities
|
9,899 | 11,859 | ||||
|
Shareholders’ equity:
|
||||||
|
Common stock
|
110 | 109 | ||||
|
Additional paid-in capital
|
26,732 | 25,940 | ||||
|
Retained earnings
|
25,956 | 24,708 | ||||
|
Accumulated other comprehensive loss, net of tax
|
(82) | (55) | ||||
|
Treasury stock, at cost
|
(18,220) | (17,333) | ||||
|
Total shareholders’ equity
|
34,496 | 33,369 | ||||
|
Total liabilities and shareholders’ equity
|
$ | 44,395 | $ | 45,228 | ||
|
TRANSACT TECHNOLOGIES INCORPORATED
|
|
RECONCILIATION OF GAAP EARNINGS FINANCIAL MEASURES TO CORRESPONDING
NON-GAAP FINANCIAL MEASURES
|
|
(Unaudited)
|
(In thousands, except percentages and per share amounts)
|
Three months ended
June 30, 2013
|
|||||||||
|
Reported
|
Adjustments(1)
|
Adjusted
Non-GAAP
|
|||||||
|
Operating expenses
|
$ | 4,645 | $ | 143 | $ | 4,788 | |||
|
% of net sales
|
29.4% | 30.3% | |||||||
|
Operating income
|
1,807 | (143) | 1,664 | ||||||
|
% of net sales
|
11.4% | 10.5% | |||||||
|
Income before income taxes
|
1,803 | (143) | 1,660 | ||||||
|
Income tax provision
|
588 | (48) | 540 | ||||||
|
Net income
|
1,215 | (95) | 1,120 | ||||||
|
Diluted net income per share
|
$ | 0.14 | $ | (0.01) | $ | 0.13 | |||
|
(1)
|
Adjustments include (i) $200 of income related to an adjustment to accrued contingent consideration from the Printrex acquisition and (ii) $57 of legal and other expenses related to the lawsuit with Avery Dennison Corporation. Such adjustments were tax effected using an effective tax rate of 33.5%.
|
|
|
(In thousands, except percentages and per share amounts)
|
Three months ended
June 30, 2012
|
|||||||||
|
Reported
|
Adjustments(2)
|
Adjusted
Non-GAAP
|
|||||||
|
Operating expenses
|
$ | 5,063 | $ | (534) | $ | 4,529 | |||
|
% of net sales
|
31.9% | 28.6% | |||||||
|
Operating income
|
779 | 534 | 1,313 | ||||||
|
% of net sales
|
4.9% | 8.3% | |||||||
|
Income before income taxes
|
794 | 534 | 1,328 | ||||||
|
Income tax provision
|
286 | 192 | 478 | ||||||
|
Net income
|
508 | 342 | 850 | ||||||
|
Diluted net income per share
|
$ | 0.06 | $ | 0.04 | $ | 0.09 | |||
|
(2)
|
Adjustments include (i) $471 of legal and other expenses related to the lawsuit with Avery Dennison Corporation and (ii) a restructuring charge of $63 for employee termination benefits and moving expenses associated with the closing of the Printrex manufacturing facility in San Jose, CA during 2012, tax effected using an effective tax rate of 36.0%.
|
|
TRANSACT TECHNOLOGIES INCORPORATED
|
|
RECONCILIATION OF GAAP EARNINGS FINANCIAL MEASURES TO CORRESPONDING
NON-GAAP FINANCIAL MEASURES
|
|
(Unaudited)
|
(In thousands, except percentages and per share amounts)
|
Six months ended
June 30, 2013
|
|||||||||
|
Reported
|
Adjustments(3)
|
Adjusted
Non-GAAP
|
|||||||
|
Operating expenses
|
$ | 9,676 | $ | (56) | $ | 9,620 | |||
|
% of net sales
|
31.4% | 31.2% | |||||||
|
Operating income
|
3,209 | 56 | 3,265 | ||||||
|
% of net sales
|
10.4% | 10.6% | |||||||
|
Income before income taxes
|
3,241 | 56 | 3,297 | ||||||
|
Income tax provision
|
866 | 19 | 885 | ||||||
|
Net income
|
2,375 | 37 | 2,412 | ||||||
| $ | 0.27 | $ | 0.00 | $ | 0.27 | ||||
|
(3)
|
Adjustments include (i) $200 of income related to an adjustment to accrued contingent consideration from the Printrex acquisition and (ii) $256 of legal and other expenses related to the lawsuit with Avery Dennison Corporation. Such adjustments were tax effected using an effective tax rate of 33.5%.
|
(In thousands, except percentages and per share amounts)
|
Six months ended
June 30, 2012
|
|||||||||
|
Reported
|
Adjustments(4)
|
Adjusted
Non-GAAP
|
|||||||
|
Operating expenses
|
$ | 9,931 | $ | (588) | $ | 9,343 | |||
|
% of net sales
|
29.7% | 28.0% | |||||||
|
Operating income
|
2,689 | 588 | 3,277 | ||||||
|
% of net sales
|
8.0% | 9.8% | |||||||
|
Income before income taxes
|
2,682 | 588 | 3,270 | ||||||
|
Income tax provision
|
966 | 212 | 1,178 | ||||||
|
Net income
|
1,716 | 376 | 2,092 | ||||||
| $ | 0.18 | $ | 0.04 | $ | 0.22 | ||||
|
(4)
|
Adjustments include (i) $471 of legal and other expenses related to the lawsuit with Avery Dennison Corporation and (ii) a restructuring charge of $117 for employee termination benefits and moving expenses associated with the closing of the Printrex manufacturing facility in San Jose, CA during 2012, tax effected using an effective tax rate of 36.0%.
|
|
TRANSACT TECHNOLOGIES INCORPORATED
|
|
RECONCILIATION OF NET INCOME TO ADJUSTED EBITDA
NON-GAAP FINANCIAL MEASURES
|
|
(Unaudited)
|
|
Three Months Ended
|
|||||
|
(In thousands)
|
June 30,
|
||||
|
2013
|
2012
|
||||
|
Net income
|
$ | 1,215 | $ | 508 | |
|
Interest (income) expense, net
|
- | (2) | |||
|
Income tax provision
|
588 | 286 | |||
|
Depreciation and amortization
|
432 | 438 | |||
|
EBITDA
|
2,235 | 1,230 | |||
|
Share-based compensation expense
|
142 | 127 | |||
|
Legal fees associated with lawsuit
|
57 | 471 | |||
|
Business consolidation and restructuring
|
- | 63 | |||
|
Adjustment to accrued contingent
consideration
|
(200) | - | |||
|
Adjusted EBITDA
|
$ | 2,234 | $ | 1,891 | |